ResearcherTokushima UniversityActive in the last 2 years
Shinichiro Yamada
Matched on ORCID iD 0000-0003-3847-751X; OpenAlex author ID A5004189291. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- Outcomes of remnant pancreatic resection for recurrent pancreatic cancer Co-author DOI 10.21203/rs.3.rs-4026151/v1↗
- Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12957-021-02205-6↗
- Value of the CRP-albumin ratio in patients with resectable pancreatic cancer. Co-author DOI 10.2152/jmi.68.244↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yu Saito · 3 shared papers, 2021–2024 · strength 0.50
- Paper Outcomes of remnant pancreatic resection for recurrent pancreatic cancer DOI 10.21203/rs.3.rs-4026151/v1↗
- Paper Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12957-021-02205-6↗
- Paper Value of the CRP-albumin ratio in patients with resectable pancreatic cancer. DOI 10.2152/jmi.68.244↗
- Tetsuya Ikemoto · 3 shared papers, 2021–2024 · strength 0.50
- Paper Outcomes of remnant pancreatic resection for recurrent pancreatic cancer DOI 10.21203/rs.3.rs-4026151/v1↗
- Paper Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12957-021-02205-6↗
- Paper Value of the CRP-albumin ratio in patients with resectable pancreatic cancer. DOI 10.2152/jmi.68.244↗
- Mitsuo Shimada · 3 shared papers, 2021–2024 · strength 0.50
- Paper Outcomes of remnant pancreatic resection for recurrent pancreatic cancer DOI 10.21203/rs.3.rs-4026151/v1↗
- Paper Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12957-021-02205-6↗
- Paper Value of the CRP-albumin ratio in patients with resectable pancreatic cancer. DOI 10.2152/jmi.68.244↗
- Hiroki Teraoku · 1 shared paper, 2024 · strength 0.23
- Takayuki Noma · 1 shared paper, 2024 · strength 0.23
- Yusuke Arakawa · 1 shared paper, 2021 · strength 0.13
- Masaaki Nishi · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.